Skip to the page

Data / Form D filings / VANQUA BIO, INC.

VANQUA BIO, INC.: Form D filings

VANQUA BIO, INC., a biotechnology company in Chicago, IL, filed 3 Form D notices with the SEC between 2019 and 2024. The latest, on July 5, 2024, reports $45 million sold of a $45 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1375 W Fulton Street, STE. 600, Chicago, IL, 60607
Phone
(773) 360-1673
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1790072

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 5, 2024New notice$44,979,987$44,979,98712Feb 15, 2024sec.gov
Sep 15, 2021New notice$84,999,987$84,999,98711Aug 27, 2021sec.gov
Oct 7, 2019New notice$18,000,000$6,000,000$12,000,0001Sep 20, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jonathan SilversteinDirector
Rand SutherlandDirector
Bernard DavitianDirector
Uya ChuluunbaatarDirector
James SullivanExecutive Officer, Director
Mona AshiyaDirector

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Jul 1, 2024 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what VANQUA BIO, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.